Efficacy and safety of choline alphoscerate for amnestic mild cognitive impairment: a randomized double-blind placebo-controlled trial
Clinical Research Information Service; Osong (Chungcheongbuk-do): Korea Centers for Disease Control and Prevention, Ministry of Health and Welfare (Republic of Korea); KCT0008797; A 12-week, multicenter, randomized, double-blind, placebo-controlled human application study to evaluate the efficacy and safety of SH_CAPK08 on cognitive function improvement in mild cognitive decline.
Authors
- Geum Duck Park
- Se Joo Kim (ORCID: https://orcid.org/0000-0002-5438-8210)
- Jongwook Jeon (ORCID: https://orcid.org/0000-0002-5232-650X)
- Jhin Goo Chang (ORCID: https://orcid.org/0000-0003-3024-4893)
- Changwoo Han (ORCID: https://orcid.org/0000-0001-9596-1151)
- Woo Jung Kim (ORCID: https://orcid.org/0000-0002-4963-4819)
- Seung Hoon Lee (ORCID: https://orcid.org/0000-0002-0417-2120)
- Su Young Lee (ORCID: https://orcid.org/0000-0003-3125-3409)
Institutions
- Yonsei University (KR)
- Severance Hospital (KR)
- Korea Testing & Research Institute (KR)
- Myongji Hospital (KR)
- Yonsei University Health System (KR)
Publication Details
- Journal
- BMC Geriatrics
- Published
- 2024-09-19
- DOI
- https://doi.org/10.1186/s12877-024-05366-7
- Citations
- 12
- Primary Topic
- Neurological Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.97